A costing statement has been produced because there is variation in current clinical practice across the country. Therefore, we encourage organisations to evaluate their own practices against the recommendations in the guidance and assess costs and savings locally. Some of the resource effects to be considered locally are discussed in the statement.
The statement has been prepared in consultation with experts working in this area and the company/sponsor where appropriate. It has been approved for publication by NICE.
This resource is an implementation tool and should be used alongside the published guidance. The information does not supersede or replace the guidance itself.
The Institute would welcome feedback from users to inform the development of future templates. Please email your comments to email@example.com
This page was last updated: 25 June 2015